Advocacy and Constructive Dissent Questions

Direct answer

I present the trade-off in terms the stakeholder cares about (cost of a bad decision reaching customers versus the cost of a short delay), and I look for a reduced-but-real validation step rather than treating it as a binary between full testing and none at all.

Structured elaboration

For pressure to skip testing specifically:

1. Translate "skip testing" into its actual failure mode. For a model or a pipeline, that usually means a specific type of error reaching real customers at volume, not an abstract quality concern.
2. Offer a minimum-viable validation, not full validation or nothing. A smaller labeled sample, a shadow run, or a narrower holdout can catch most of the risk in a fraction of the time.
3. Make the deadline cost of getting it wrong explicit, since a compressed shortcut that causes an incident usually costs more time than the validation would have.

Worked example

A stakeholder wanted to launch a fraud-detection model without running it against the full holdout test set (data set aside and never used in training, kept only to check real-world performance), to hit an end-of-quarter date. I proposed a compromise instead of an outright no: run a fast sanity check against a smaller labeled sample large enough to catch a gross miscalibration, meaning the model's predicted risk scores being way off from how often fraud actually happens, and deploy in shadow mode for the first week, meaning it scores transactions without actually blocking them, while the existing system stays in charge of real decisions.

Sizing that sample is the part that gets waved at, and it is worth doing out loud, because fraud is rare and rarity is what breaks the intuition. A few hundred transactions drawn at random is close to useless here: at a 1 percent fraud rate, 300 random transactions contain about 3 real fraud cases, and the 95 percent interval around that observed rate runs from roughly 0.3 percent to 2.9 percent, so a model two or three times out of calibration still sails through. The same few hundred labels become informative if you spend them where the model is making its strongest claim: draw them from the top-risk decile, where the model is predicting a high fraud rate, and a few hundred is enough to tell a true rate near the prediction from one at half or a quarter of it. So the compromise was a few hundred labels stratified on the model's own scores, not a few hundred labels at random, and the difference between those two sentences is the whole value of the check.

That gave the stakeholder a deployment on the original date and a real check on the largest risk, though I was explicit that shadow mode is not the same as the model being live, since it scores without blocking, so enforcement would follow the shadow week rather than land on the date itself.

The shadow week surfaced a calibration issue on a specific transaction type that the smaller sanity check hadn't caught, and we fixed it before the model was ever allowed to make a real blocking decision. The eventual outcome was the model went fully live about a week after the original target, which the stakeholder accepted readily once they saw the specific issue the shadow run had caught. It is worth being straight about the shape of that trade rather than presenting it as having cost nothing: the compromise did not preserve the original enforcement date, it spent about a week to catch a calibration bug before the model could start declining legitimate transactions for an entire customer segment.

Trade-offs & pitfalls

A reduced validation step is a genuine compromise, not full safety; it needs to be sized to actually catch the highest-risk failure mode, not just to look like due diligence. If a stakeholder pushes for skipping even the reduced check, that's the point to be direct that this isn't about protecting a process, it's about the specific harm a false positive or false negative would cause a real customer.

Direct answer

I'll walk through a specific case, a marketing attribution model, what made me suspicious of it, what I actually did about it rather than just object, and what I'd do differently today.

Structured elaboration

When you disagree with a data-backed decision on the grounds that the analysis itself is flawed, the useful pattern is: distinguish "I don't like the conclusion" from "the method has a specific, nameable flaw," only escalate for the latter; name the exact suspected issue: a specific confound (an outside factor driving both the change and the outcome, making it look like one caused the other), a missing counterfactual (what would have happened without the change, needed to claim the change caused the result), or a biased sample, rather than a vague "the data feels off"; propose a fast additional check before demanding the whole analysis be redone; and bring the new evidence back to the room, ready to be wrong yourself.

Worked example

A growth team credited a paid-social channel with driving a 20% lift in signups, based on last-click attribution (crediting the very last ad someone saw before converting), and wanted to double the channel's budget the same week. I suspected last-click was overcrediting a channel that ran heavy retargeting, showing ads to people who were already about to sign up anyway. Instead of just voicing disagreement, I ran a quick incrementality check: a holdout group, a randomly chosen slice of the target audience shown no ads from that channel at all, for one week, to see the true causal lift rather than the correlational number from last-click. I brought both results to the meeting side by side. The holdout showed the true incremental lift was closer to 4%, not 20%. The team held the budget flat instead of doubling it, redirected the planned increase to a channel with a cleaner incrementality read, and the holdout test became a standing check before any future budget-doubling decision on that team.

Trade-offs and pitfalls

A holdout test costs a week of "lost" spend efficiency on the channel being tested, name that cost when you propose it so it doesn't feel like free rigor. If you can't run a clean test in the time available, say so plainly rather than let an under-powered check pass as confirmation either way. Looking back, I'd propose the holdout before the budget number even started circulating, since a number with momentum behind it is much harder to walk back than one that never got presented alone.

Direct answer

Validate the stakeholder's experience first, since a gut feeling built on years of pattern recognition is a form of data too, then reframe the conversation from "you are wrong" to "let's find out together" by proposing a cheap, specific way to test whose model of the world is right.

Approach

• Acknowledge specifically what their experience is based on, not a generic "I hear you," but naming what they have actually seen and for how long.
• Find the real point of disagreement: is it the data quality, the interpretation of the result, or the recommendation drawn from it. These need different responses.
• Reframe your analysis as a hypothesis to test rather than a verdict you are delivering.
• Propose a low-cost way to resolve the disagreement empirically: a small controlled test, a historical lookback, or a narrower pilot.
• Size the test before you run it, against the effect you are actually trying to see. A test that is cheap but too small to detect the effect in question is worse than no test, because an inconclusive result will be read by each side as confirming what they already believed. Ask what the normal variation is in whatever you are measuring, and how many units you need for the expected effect to stand clearly above it.
• Agree in advance on what result would change each person's mind, so the test actually settles something instead of becoming another round of the same argument.

Worked example

A regional sales director dismissed a regression (a statistical model that estimates how much one factor, here running a promotion, moves an outcome once other differences are accounted for) showing a promotion type had a positive lift, saying it "doesn't work here" based on years of running promotions in that market. Instead of re-presenting the model, I said, "you've run promotions in this region for years, if the model is missing something, it's probably something specific to this market, what's different here?" That surfaced something not in my data window: a similar promotion had run heavily just the prior quarter, likely causing discount fatigue that the model could not see. I reran the analysis excluding the confounded period, which lowered but did not eliminate the estimated lift, and proposed a matched-store test before any region-wide rollout.

The design mattered more than the idea. My first instinct was a quick read on a couple of comparable stores, and that would have been useless: one treated store against one control cannot tell a promotion lift apart from one store's ordinary week-to-week swing, and the lift I was now defending was the smaller post-correction one, which is exactly the case where an undersized test comes back ambiguous and each side claims it. So we matched stores on pre-period sales and seasonality, ran roughly twenty treated against twenty control stores for six weeks, and wrote down beforehand that anything under the post-correction estimate would count as the director being right. The test came back with a smaller but clearly positive effect, giving both of us a shared, tested number to plan around instead of a stalemate between a model and a gut feeling.

Trade-offs and pitfalls

There is a real failure mode of over-validating to the point of quietly abandoning a finding you still believe is correct, just to keep the peace, that is not advocacy, it is avoidance. There is an equal failure mode of responding to distrust by presenting more slides louder, when the actual blocker is trust in the analysis, not the volume of evidence behind it. A third, quieter failure is agreeing to a test that is too small to settle the question, which looks collaborative and buys you nothing: the ambiguous result restarts the same argument with the added cost of having spent a quarter on it. The senior move is diagnosing which one you are dealing with before choosing a response.

Direct answer

I would not treat "urgency versus validation" as a binary. I would put a number on both sides of the trade-off using the executive's own frame (revenue and churn), so the conversation moves from opinions to a shared calculation, then recommend the smallest deployment that gets real signal without betting the whole customer base on an unvalidated model.

Structured elaboration

Evaluating and presenting the situation:

• Separate the two claims. "It may increase short-term revenue" and "insufficient validation" are both estimates; find out how confident each one actually is, and what "insufficient" means concretely (missing test coverage on a segment, no shadow-mode comparison, no fairness check).
• Build quantitative scenarios, not one number. A best case, a base case, and a case where the missing validation turns out to matter, each translated into the same units (revenue and retained customers) so they are directly comparable.
• Compare them over time, not per month. This is where most versions of this argument quietly lose. A revenue lift is a flow that repeats at the same size each month. An increase in churn is a stock that accumulates: each month it goes unnoticed, another cohort leaves and stays gone, so the monthly loss grows while the monthly gain does not. Comparing one month of each makes the upside look strictly larger and hides the whole risk.
• Recommend a course of action that is not "yes" or "no." Usually a phased or shadow deployment that captures most of the urgency (a real launch date, real learning) while capping the downside (a rollback trigger, a limited audience, a time-boxed validation sprint running in parallel).

Worked example

A recommendation model was proposed for immediate full rollout to lift short-term revenue, with fairness and long-term retention testing skipped for time. I built three back-of-envelope scenarios using the executive's own numbers, and kept one population in front of us the whole time so every figure could be checked against the others: about 40,000 affected customers generating roughly $4M per month, which is an average of $100 per customer per month.

The upside: if the model lifts revenue by 3 percent on that $4M per month, that is about $120,000 per month, and it repeats at roughly that size each month.

The downside: if the missing validation surfaces a churn effect similar to comparable launches, a rough 1 to 2 percentage point uptick in monthly churn on those 40,000 customers means 400 to 800 customers leaving per month who otherwise would not have. At $100 each that is $40,000 to $80,000 per month of recurring revenue gone, and, crucially, it is gone for good: the second month adds another 400 to 800 on top of the first month's loss, the third adds more again.

Carrying that forward was the part that changed the conversation. In the first month the upside wins easily, $120,000 against $40,000 to $80,000, which is exactly why this kind of launch feels safe. But the cumulative comparison crosses over fast. At the mild 1-point end, cumulative upside and cumulative churn loss are both $600,000 by month five and the churn side is ahead from month six onward. At the 2-point end the crossover is month two, and by month six the cumulative loss is about $1.68M against $720,000 of cumulative gain. So the real question is not whether to ship, it is how long the model can run unvalidated before the loss outruns the gain, and the honest answer was somewhere between two and five months.

I walked through this arithmetic live rather than asserting a conclusion, then recommended: launch to 20 percent of eligible users immediately (capturing most of the urgency), run the two skipped validation checks in parallel against that cohort, and set an explicit go/no-go date two weeks out for the remaining 80 percent. Two weeks sits well inside even the aggressive crossover, which is what made the phased plan defensible rather than arbitrary. The executive accepted it; the full rollout proceeded on schedule because the parallel checks came back clean, but the guardrail meant we would have caught a problem in two weeks instead of a quarter if they hadn't.

Trade-offs and pitfalls

The pitfall on the executive's side is discounting a diffuse, delayed cost (churn drifting up over months) against a concrete, immediate one (a specific revenue number this quarter); make the delayed cost equally concrete or it will lose the comparison by default, and the way to make it concrete is to accumulate it rather than quote it per month. The pitfall on your side is presenting only the downside case, which reads as obstruction rather than analysis: show the upside case honestly too, or the exec has no reason to trust your numbers. The quieter pitfall is inconsistent arithmetic across your own slides, an affected base on one line and a customer count and average price on another that do not multiply back to it; the first person who checks stops believing any of it. Senior candidates propose the phased option before being asked for a compromise; junior candidates wait to be told to find a middle ground.

Direct answer

Bring the metric the audience actually cares about, not just the one that was easiest to measure, show the size of the effect along with how much it could plausibly vary run to run, and separate "is this real" from "is this worth doing," since those are two different questions with two different answers.

What to bring to engineers

The specific bottleneck metric that changed, for example p95 or p99 latency (the 95th or 99th percentile, meaning the value that 95 or 99 percent of requests fall under), memory footprint, or error rate under load, measured the same way before and after under the same environment and load, ideally across several repeated runs rather than a single before/after snapshot, since one run cannot distinguish a real improvement from noise. Explain the mechanism for why it changed, so the result is explainable rather than a coincidence nobody can defend.

What to bring to product owners

Translate the technical metric into what they actually measure success by: user-facing latency into conversion or task-completion rate, cost improvements into infrastructure spend, plus the cost and risk of making the change itself (engineering time, rollout risk). Be explicit about which half of that translation you measured and which half you are projecting, because they usually have very different evidence behind them.

Statistical versus practical significance

Statistical significance asks whether a measured difference is likely real rather than noise, typically assessed with repeated measurements and an uncertainty range around the result. Practical significance asks something different: is the size of that difference actually big enough to matter for the business or the user, regardless of how confident you are that it is real. A change can be statistically significant but practically trivial, a very precisely measured but tiny latency improvement nobody would ever notice, or it can look practically large from a handful of runs while still being statistically uncertain, meaning it could disappear with more data.

Worked example

An engineer optimizes a database query path on the checkout critical path and brings this to the review.

The statistical case, for the engineers: nine runs before and nine after, same hardware, same synthetic load. Before, p95 latency across the nine runs came in between 318 and 336 ms, median 326. After, between 245 and 262 ms, median 253. So the improvement is 73 ms, about 22 percent, and the two sets of runs do not overlap at all: the worst run after the change, 262 ms, is still faster than the best run before it, 318 ms. The run-to-run spread is about 18 ms in each set, so the 73 ms gap is roughly four times the largest amount the measurement wanders on its own. That is what makes the result hard to dismiss as luck, and it is a claim the single-number version ("326 down to 253") cannot support. The mechanism is stated alongside it: one query per checkout was doing a full scan that an added index now serves directly.

The practical case, for the product owner, and deliberately framed differently: 73 ms off a page that a user waits on before their order confirms. The honest version of this claim has two parts. The measured part is the latency. The projected part is what that does to completion rate, which has not been measured here, and the engineer says so rather than implying it is part of the same evidence. What makes 73 ms worth arguing for is that it sits on the checkout path, where published work across the industry has repeatedly found that latency in this range moves completion, and that the change costs two days of engineering and carries low rollout risk because the index can be dropped. If the same 73 ms had come off an internal admin report run twice a day, the statistical case would be identical and the practical case would be close to zero. If the product owner wants the conversion number rather than the argument, the answer is to ship it as an experiment with a holdout and measure it, which is a separate and more expensive piece of work.

Trade-offs and pitfalls

Reporting a single before/after number with no sense of run-to-run variance cannot distinguish a real improvement from a lucky measurement. A change that is statistically airtight but practically irrelevant, presented as a win because the numbers look clean, is a common and misleading pattern; a mature answer states both and lets the audience judge whether the change is worth its cost and risk given the actual size of the effect. The third pitfall is quietly promoting a projection into the evidence: saying "this lifts conversion" when what you measured was latency, which is the fastest way to lose the product owner's trust the first time someone checks.